Our findings highlight the pro-apoptotic and anti-autophagic roles of HOXA9 in skin tissue, support our previous finding that HOXA9 acts as tumor suppressor in cSCC, and emphasize a newly identified HOXA9- NF-κB axis that may provide novel intervention targets for cSCC therapy. This evidence concerns the gene HOXA9 and neoplasm.